Comparative evaluation of anti-inflammatory and antioxidant effects of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention: A prospective cohort study
Shanmugapriya Vinayagam, Niti Mittal, Ashwani Kumar, Manjulata Kumawat, Aparna Parmar, Vijay Kalra, Joshuah Jebaraj · 2026
Read Comparative evaluation of anti-inflammatory and antioxidant effects of prasugrel versus clopidogrel in patients undergoing percutaneous coronary intervention: A prospective cohort study by Shanmugapriya Vinayagam, Niti Mittal, Ashwani Kumar, Manjulata Kumawat, Aparna Parmar, Vijay Kalra, Joshuah Jebaraj (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13610749.txt.
Description
Vinayagam and co-authors compare two platelet drugs for effects beyond clot prevention in a 2026 prospective cohort study. Both drugs, prasugrel and clopidogrel, are paired with aspirin after coronary stent procedures for acute heart syndromes. How their effects on inflammation and oxidative stress compare was not clear.
About one hundred patients aged eighteen to sixty-five took part in two equal study groups. Blood markers of inflammation and antioxidant capacity were measured at the start and again at four weeks. The group on the newer drug showed a much larger drop in the inflammation marker. The paper also reports how antioxidant capacity changed in each group.
Catalog record
| CREATOR | Shanmugapriya Vinayagam, Niti Mittal, Ashwani Kumar, Manjulata Kumawat, Aparna Parmar, Vijay Kalra, Joshuah Jebaraj |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 20 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |